Indeed, regulating the Wnt/GSK-3β/β-catenin signaling pathway by ginsenoside alleviate oxidative stress, neuro-inflammation, protect neurons, and improve the cognitive impairment in AD (Yang et al. 2022; Zhang et al. 2020) (Fig. 6). This evidence concerns the gene GSK3B and Alzheimer disease.